deltatrials
Terminated NA INTERVENTIONAL 1-arm NCT02799823

Transfemoral Replacement of Aortic Valve With HLT MeriDIAN Valve Early Feasibility Trial (RADIANT)

Sponsor: HLT Inc.

Updated 21 times since 2017 Last updated: May 29, 2023 Started: Apr 27, 2017 Primary completion: Jan 20, 2023 Completion: Jan 20, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

HLT Business Decision

Other terminated trials from HLT Inc.

More terminations from HLT Inc.

A NA clinical study on Aortic Valve Stenosis, this trial is terminated or withdrawn. The trial is conducted by HLT Inc. and has accumulated 21 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Mar 2017 · 28 days · monthly snapshot~Mar 2017 – ~Jun 2017 · 3 months · monthly snapshot~Jun 2017 – ~Dec 2017 · 6 months · monthly snapshot~Dec 2017 – ~Mar 2018 · 3 months · monthly snapshot~Mar 2018 – ~May 2018 · 2 months · monthly snapshot~May 2018 – ~Jun 2018 · 31 days · monthly snapshot~Jun 2018 – ~Aug 2019 · 14 months · monthly snapshot~Aug 2019 – ~Feb 2020 · 6 months · monthly snapshot~Feb 2020 – ~Apr 2020 · 2 months · monthly snapshot~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~May 2021 · 2 months · monthly snapshot~May 2021 – ~Mar 2022 · 10 months · monthly snapshot~Mar 2022 – ~May 2022 · 2 months · monthly snapshot~May 2022 – ~Jul 2022 · 2 months · monthly snapshot~Jul 2022 – ~Jun 2023 · 11 months · monthly snapshot~Jun 2023 – ~Jul 2024 · 13 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 10 months · monthly snapshot

Change History

21 versions recorded
  1. Sep 2025 — Present [monthly]

    Terminated NA

  2. Sep 2024 — Sep 2025 [monthly]

    Terminated NA

  3. Jul 2024 — Sep 2024 [monthly]

    Terminated NA

  4. Jun 2023 — Jul 2024 [monthly]

    Terminated NA

    Status: RecruitingTerminated

  5. Jul 2022 — Jun 2023 [monthly]

    Recruiting NA

Show 16 earlier versions
  1. May 2022 — Jul 2022 [monthly]

    Recruiting NA

  2. Mar 2022 — May 2022 [monthly]

    Recruiting NA

    Status: Active Not RecruitingRecruiting

  3. May 2021 — Mar 2022 [monthly]

    Active Not Recruiting NA

  4. Mar 2021 — May 2021 [monthly]

    Active Not Recruiting NA

  5. Jan 2021 — Mar 2021 [monthly]

    Active Not Recruiting NA

  6. Apr 2020 — Jan 2021 [monthly]

    Active Not Recruiting NA

  7. Feb 2020 — Apr 2020 [monthly]

    Active Not Recruiting NA

  8. Aug 2019 — Feb 2020 [monthly]

    Active Not Recruiting NA

  9. Jun 2018 — Aug 2019 [monthly]

    Active Not Recruiting NA

  10. May 2018 — Jun 2018 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting

  11. Mar 2018 — May 2018 [monthly]

    Recruiting NA

  12. Dec 2017 — Mar 2018 [monthly]

    Recruiting NA

  13. Jun 2017 — Dec 2017 [monthly]

    Recruiting NA

    Status: Not Yet RecruitingRecruiting

  14. Mar 2017 — Jun 2017 [monthly]

    Not Yet Recruiting NA

  15. Feb 2017 — Mar 2017 [monthly]

    Not Yet Recruiting NA

  16. Jan 2017 — Feb 2017 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • HLT Inc.
Data source: HLT Inc.

For direct contact, visit the study record on ClinicalTrials.gov .